Hillman Value Fund HCMAX

Medalist Rating as of | See Hillman Investment Hub
  • NAV / 1-Day Return 28.24  /  −0.95 %
  • Total Assets 79.3M
  • Adj. Expense Ratio
    0.950%
  • Expense Ratio 0.950%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Mid Value
  • Min. Initial Investment 5,000
  • Status Open
  • TTM Yield 2.40%
  • Turnover 42%

USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:31 AM GMT+0

Morningstar’s Analysis HCMAX

Will HCMAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Hillman Value holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HCMAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 30.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Umb Cash Deposit Sweep

3.45 3M
Cash and Equivalents

West Pharmaceutical Services Inc

3.25 3M
Healthcare

Veeva Systems Inc Class A

3.17 2M
Healthcare

CVS Health Corp

3.10 2M
Healthcare

Baxter International Inc

3.08 2M
Healthcare

United Parcel Service Inc Class B

3.06 2M
Industrials

Warner Bros. Discovery Inc Ordinary Shares - Class A

2.98 2M
Communication Services

DuPont de Nemours Inc

2.96 2M
Basic Materials

Taiwan Semiconductor Manufacturing Co Ltd ADR

2.92 2M
Technology

The Kraft Heinz Co

2.87 2M
Consumer Defensive

Sponsor Center